/Companies

K36 Therapeutics

Founded 2021 · 14 employees on LinkedIn · 6 known investors

Find your way into K36 Therapeutics

Sign up to see every warm intro you have to K36 Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the K36 Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A biotechnology company developing cancer therapies for patients with unmet medical needs. Its clinical pipeline includes the KTX-1001 and KTX-2001 programs.

Investors · 6

Also in the syndicate · 2

Bristol Myers SquibbBristol Myers Squibb Company

Funding

SEC filings, press & company announcements

$70M disclosed across 1 round · 2023

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does K36 Therapeutics do?
A biotechnology company developing cancer therapies for patients with unmet medical needs. Its clinical pipeline includes the KTX-1001 and KTX-2001 programs.
Who are K36 Therapeutics's investors?
K36 Therapeutics's investors include Atlas Venture, F-Prime Capital, Nextech Invest, Eight Roads Ventures.
How much funding has K36 Therapeutics raised?
K36 Therapeutics has disclosed $70M raised across 1 round.